↓ Skip to main content

Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta- analysis

Overview of attention for article published in BMC Cancer, January 2012
Altmetric Badge

Mentioned by

twitter
1 tweeter

Readers on

mendeley
37 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta- analysis
Published in
BMC Cancer, January 2012
DOI 10.1186/1471-2407-12-17
Pubmed ID
Authors

Ying Zhou, Xin Yin, Jun Ying, BoHeng Zhang

Abstract

There have been conflicting reports about serum golgi protein 73 (GP73) as one of the most promising serum markers for the diagnosis of hepatocellular carcinoma (HCC). This study was to make a systematic review about the diagnostic accuracy of serum GP73 versus alpha-fetoprotein (AFP) for HCC.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 37 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 2 5%
United Kingdom 1 3%
Unknown 34 92%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 9 24%
Researcher 6 16%
Student > Postgraduate 5 14%
Student > Doctoral Student 5 14%
Student > Master 4 11%
Other 6 16%
Unknown 2 5%
Readers by discipline Count As %
Medicine and Dentistry 14 38%
Agricultural and Biological Sciences 6 16%
Biochemistry, Genetics and Molecular Biology 5 14%
Engineering 2 5%
Immunology and Microbiology 2 5%
Other 5 14%
Unknown 3 8%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 January 2012.
All research outputs
#7,482,417
of 9,696,449 outputs
Outputs from BMC Cancer
#2,690
of 4,069 outputs
Outputs of similar age
#175,402
of 259,549 outputs
Outputs of similar age from BMC Cancer
#48
of 72 outputs
Altmetric has tracked 9,696,449 research outputs across all sources so far. This one is in the 12th percentile – i.e., 12% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,069 research outputs from this source. They receive a mean Attention Score of 3.9. This one is in the 18th percentile – i.e., 18% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 259,549 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 72 others from the same source and published within six weeks on either side of this one. This one is in the 13th percentile – i.e., 13% of its contemporaries scored the same or lower than it.